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Abstract
Apoptosis is a form of programmed cell death critical for development and homeostasis in multicellular organisms.
Apoptosis-like cell death (ALCD) has been described in several fungi, including the opportunistic human pathogen
Cryptococcus neoformans. In addition, capsular polysaccharides of C. neoformans are known to induce apoptosis in host
immune cells, thereby contributing to its virulence. Our goals were to characterize the apoptotic signaling cascade in C.
neoformans as well as its unique features compared to the host machinery to exploit the endogenous fungal apoptotic
pathways as a novel antifungal strategy in the future. The dissection of apoptotic pathways revealed that apoptosis-
inducing factor (Aif1) and metacaspases (Mca1 and Mca2) are independently required for ALCD in C. neoformans. We show
that the apoptotic pathways are required for cell fusion and sporulation during mating, indicating that apoptosis may occur
during sexual development. Previous studies showed that antifungal drugs induce ALCD in fungi and that C. neoformans
adapts to high concentrations of the antifungal fluconazole (FLC) by acquisition of aneuploidy, especially duplication of
chromosome 1 (Chr1). Disruption of aif1, but not the metacaspases, stimulates the emergence of aneuploid subpopulations
with Chr1 disomy that are resistant to fluconazole (FLC
R) in vitro and in vivo. FLC
R isolates in the aif1 background are stable
in the absence of the drug, while those in the wild-type background readily revert to FLC sensitivity. We propose that
apoptosis orchestrated by Aif1 might eliminate aneuploid cells from the population and defects in this pathway contribute
to the selection of aneuploid FLC
R subpopulations during treatment. Aneuploid clinical isolates with disomies for
chromosomes other than Chr1 exhibit reduced AIF1 expression, suggesting that inactivation of Aif1 might be a novel
aneuploidy-tolerating mechanism in fungi that facilitates the selection of antifungal drug resistance.
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Introduction
Apoptosis is a form of programmed cell death critical for
development and homeostasis in multicellular organisms [1]. The
mechanisms of apoptosis are complex and energy-dependent.
Numerous pro-and anti-apoptotic signals have to be integrated to
activate apoptotic effectors only when necessary. Mitochondria play
an important role in apoptosis by releasing several proteins, such as
cytochrome c, which triggers the proteolytic maturation of caspases
[2]. Caspases are a family of cysteine proteases that are recognized
as key components of the apoptotic machinery. Caspases proteo-
lytically cleave specific substrates, leading to the ordered disman-
tling of intracellular components during apoptotic death [3].
Caspase-independent apoptotic pathways involve the translocation
of two nucleases, apoptosis-inducing factor (AIF) and endonuclease
G (EndoG), from the mitochondria to the nucleus [4].
Features typical of apoptotic cell death, including chromatin
fragmentation and condensation and translocation of phosphati-
dylserine to the outer layer of the cellular membrane, were
described for the first time in fungi in a Saccharomyces cerevisiae cdc48
mutant [5]. Heterologous expression of mammalian pro- or anti-
apoptotic Bax or Bcl2 in yeast causes or prevents apoptosis-like cell
death (ALCD), respectively [6–8]. Subsequently, several fungal
species have been reported to undergo ALCD as a consequence of
interactions with other organisms and during development and
aging (reviewed by [9–13]). The identification and functional
analysis of core components of the apoptotic machinery has
revealed partial conservation, along with substantial differences in
function and mode of action between fungal and human proteins.
Consequently, apoptotic pathways are considered suitable targets
for novel antifungal therapies.
Cryptococcus neoformans var. neoformans undergoes ALCD when co-
cultivated with the bacterium Staphylococcus aureus and also in
response to oxidative stress induced by hydrogen peroxide [14].
Conversely, purified capsular polysaccharides from C. neoformans
are known to induce apoptosis in host immune cells, including rat
splenocytes [15,16], activated human T cells [17–19], and murine
macrophages [20–22]. Apoptosis induction is a strategy that C.
neoformans may deploy to evade host innate immune responses and
contributes to the powerful immunosuppression that accompanies
PLoS Pathogens | www.plospathogens.org 1 November 2011 | Volume 7 | Issue 11 | e1002364cryptococcosis. Because C. neoformans both induces and undergoes
apoptosis in response to different signals, its apoptotic machinery
must have unique features compared to the apoptotic-signaling
cascade of the host, which are potential new therapeutic targets.
C. neoformans has emerged as an important pathogen of
immunocompromised and immunocompetent patients, estimated
to cause 1 million new cryptococcal disease cases globally each year,
withupto600,000 fatalitiesyearly[23].Cryptococcosisisasystemic
mycosis that commonly involves the lungs and central nervous
system. Untreated cryptococcal meningitis has a mortality rate of
100%. The recommended therapy for cryptococcal meningitis,
which is intravenous amphotericin B (AMB) combined with
flucytosine [24], is associated with high toxicity and serious adverse
reactions in patients. Moreover, the high costs associated with AMB
therapieslimititsavailabilityinresource-limited regionssuchassub-
Saharan Africa. Instead, a less effective agent, fluconazole (FLC), is
widely used in these areas, and mortality remains high. FLC is a
triazole antifungal drug that inhibits the fungal cytochrome P450
lanosterol 14a-demethylase (encoded by ERG11), thereby blocking
the production of ergosterol, the main sterol of fungal membranes.
Herewe studied the apoptotic pathways of C. neoformans aimingto
identify unique features to specifically induce ALCD of this
pathogenasa noveltreatment.Wefoundanunexpected connection
between ALCD and antifungal drug resistance: the elimination of
the apoptosis-inducing factor (Aif1) stabilizes aneuploidy and
promotes the generation of FLC-resistance. Selection of FLC
R
populations with Aif1 defects occurs in vivo, and the inactivation of
Aif1-mediated ALCD in C. neoformans may explain cases of FLC
treatment failures in the clinical setting. In addition, apoptotic
pathways are involved in sexual development and the formation of
spores, which serve as infectious propagules of C. neoformans.
Results
Characterization of apoptotic pathways in Cryptococcus
neoformans
ALCD has been described in several fungal species and is
induced by different compounds and stress conditions (reviewed by
[9,11–13]). In particular, hydrogen peroxide has been reported to
trigger ALCD in C. neoformans var. neoformans [14], and so we tested
if similar conditions would induce cell death in C. neoformans var.
grubii, which is responsible for more than 90% of cryptococcal
infections worldwide [25]. Treatment of the H99 sequence
reference strain with 2 mM hydrogen peroxide for 3 hours at
37
oC induced characteristic apoptotic markers, such as DNA
fragmentation indicated by TUNEL (TdT-mediated dUTP nick
end labeling). TUNEL detects DNA fragmentation by using
terminal deoxynucleotidyl transferase (TdT) to incorporate dUTP
tagged with FITC into the blunt ends of double-stranded DNA
breaks, and is the standard method for identification and
quantification of apoptotic cells [26]. While TUNEL-FITC
positive cells were only rarely observed in untreated controls
(Figure 1A, upper panels), ,45% of wild-type cells showed
DNA degradation after treatment with hydrogen peroxide
(Figure 1B).
We also used Annexin V-FITC to bind to phosphatidylserine
(PS), a plasma membrane phospholipid that is externalized to the
outer layer during apoptosis. Annexin V-FITC does not bind cells
with an intact plasma membrane, but can falsely detect the PS
present in the inner membrane of lysed (necrotic) cells. Therefore,
simultaneous staining with the vital dye propidium iodide (PI)
allows the discrimination of early apoptotic (FITC+,P I 2) and late
apoptotic or necrotic yeast cells (FITC+,P I +). The percentage of
WT cells staining positive with Annexin V-FITC but negative with
PI (apoptotic cells) rose to ,42% after treatment with hydrogen
peroxide (Figure S1A, green bars).
To find potential regulators of ALCD in C. neoformans, functional
homologs of the major apoptotic machinery identified from S.
cerevisiae were used to search the H99 genome database. The
following homologs were identified as first reciprocal BLASTp hits:
cytochrome c oxidase subunit 1 (COX1, CNAG_09009); inhibitor of
apoptosis protein (IAP1, CNAG_04708), and the caspase-indepen-
dent nucleases apoptosis-inducing factor (AIF1, CNAG_04521) and
endonuclease G (ENDOG CNAG_02204). Two metacaspases were
identified in the H99 genome using the S. cerevisiae Mca1p: MCA1
(CNAG_04636; 60% identity and 4e-103) and MCA2
(CNAG_06787, 44% identity and 1e-88). Interestingly, no apparent
high-temperature resistance A homolog (HtrA2, also called
Nma111p in yeast for nuclear mediator of apoptosis) was found.
C. neoformans does not have apparent homologs of the apoptotic
protease activating factor (APAF) and the poly(ADP-ribose)
polymerase (PARP), which are present in filamentous fungi but
absent in S. cerevisiae. Of note, multiple attempts to disrupt the COX1
gene were unsuccessful (Toffaletti and Perfect, unpublished
observations) and it may therefore be an essential gene in C.
neoformans.
We generated two independent aif1, mca1 mca2, and aif1 mca1
mca2 null mutants in congenic a and a C. neoformans var. grubii
backgrounds to address whether C. neoformans has parallel caspase-
dependent and caspase-independent apoptotic pathways. After
treatment with 2 mM hydrogen peroxide, the aif1 mutants showed
a 41% reduction, and mca1 mca2 showed a 47% reduction in
TUNEL-positive cells when compared to wild-type (Figure 1B),
while the aif1 mca1 mca2 triple mutant showed a reduction of 79%.
In addition, all mutant strains showed reduced externalization of
PS revealed by Annexin V assay (Figure S1A) and did not show
increased vacuolization observed during autophagic cell death (not
shown). Finally, the aif1, mca1 mca2, and aif1 mca1 mca2 null
mutants were more resistant to 2 mM hydrogen peroxide than the
wild-type (Figure S2). Our results indicate that Aif1 and the two
metacaspases independently promote ALCD in C. neoformans.
Author Summary
Fungal pathogens can cause life-threatening diseases, and
the infections that they cause are notoriously difficult to
treat. Despite the availability of antifungal drugs, most
inhibit fungal growth but do not consistently or efficiently
eliminate the pathogen. In addition, fungal cells are very
similar to human cells, and therefore, many of the available
antifungal agents have toxic side effects. Thus, more
efficient drugs with less adverse effects are clearly needed.
We investigated apoptosis, a process in which cells become
programmed to commit suicide, in the pathogenic fungus
Cryptococcus neoformans. We studied genes that regulate
apoptosis in C. neoformans and, after inactivating three
genes involved in this pathway, we observed defects in
sexual reproduction. Such mating defects decrease the
production of spores, which are inhaled and cause
cryptococcal disease. We also showed that the absence of
one investigated apoptotic gene, aif1, resulted in the
selection of antifungal-resistant pathogens (when the
fungal cells no longer respond to the drug), which makes
treatment of the disease more difficult. The discovery of
drugs that kill fungal cells specifically without affecting the
cells of the patient being treated holds great potential.
Therefore, triggering apoptosis should be further investi-
gated as a new approach to treat fungal pathogens.
Apoptosis in Cryptococcus neoformans
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aneuploidy
Amphotericin B (AMB) and fluconazole (FLC) are antifungal
drugs widely used to treat major fungal diseases. Recent treatment
guidelines recommend the more toxic AMB-based regimens for
induction therapy instead of the better-tolerated FLC-based
regimens to treat cryptococcal meningitis, because the latter is
fungistatic and because Cryptococcus strains repeatedly exposed to
FLC can acquire direct drug resistance [27]. AMB was shown to
induce ALCD in Aspergillus fumigatus [28] and Candida albicans in
vitro [29], and in biofilms of C. albicans, Candida krusei, and Candida
parapsilosis [30]. To test if antifungal drugs would induce ALCD in
C. neoformans, we first determined if the apoptotic mutants have
increased resistance to AMB and FLC. Using Epsilometer test
strips (Etest), the aif1 and mca1 mca2 mutants showed no significant
difference in sensitivity to AMB (Table 1) and we could not detect
ALCD induction by treating wild-type cells with the minimal
inhibitory concentration of 0.125 mg/ml of AMB (Figure S1B). On
the other hand, the aif1 and mca1 mca2 mutants showed increased
resistance to FLC (Table 1). Even though FLC is a fungistatic
agent, we tested if this azole was able to induce ALCD in C.
neoformans. We could not detect ALCD induction by treating wild-
type cells with up to 64 mg/ml of FLC (Figure S1B and data not
shown) and therefore, the increased resistance of the aif1 and mca1
mca2 mutants is likely not attributable simply to a lack of cell death
induction.
We also noticed that considerably more FLC
R colonies grew
within the zone of inhibition around the FLC strip in Etest assays
Figure 1. Apoptotic pathways are conserved in C. neoformans.A . TUNEL assay indicating apoptosis-like cell death occurs following exposure
to hydrogen peroxide. Cells of wild-type serotype A H99 strain grown on YNB media treated for 3 hr with 0 (upper panels) or 2 mM (lower panels)
H2O2 were labeled with DAPI (blue fluorescence) and TUNEL (green fluorescence) and analyzed by fluorescence microscopy. Bars, 10 mm. B.
Percentage of TUNEL positive cells in wild-type H99 control and aif1, mca1 mca2, and aif1 mca1 mca2 mutant strains treated with 2 mM H2O2 and
analyzed by flow cytometry. Data represent mean 6 standard deviation. ** and *** indicates significance at p,0.01 and 0.001 compared to H99 strain
(WT MATa), respectively.
doi:10.1371/journal.ppat.1002364.g001
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(Figure 2A), a phenomenon called heteroresistance. Heteroresis-
tance to azoles, or the presence of drug-resistant cells within a
drug-sensitive population, was previously observed as an intrinsic
resistance mechanism in all serotypes of C. neoformans [31–33] and
C. gattii [34]. During these Etest experiments, resistant colonies
within the zone of inhibition were observed up to 10 times more
frequently in the aif1 deletion mutants (Figure 2A). Fluctuation
analysis using 12 independent colonies estimated that the
resistance rate to 32 mg/ml FLC is about 5 times higher in the
aif1 mutant compared to H99 (Table 2). This is not due to a higher
mutation rate in the aif1 strain because it showed similar 5-FOA
R
rates compared to the wild-type stain (5.1 and 4.5610
28
respectively).
H99 was recently reported to be able to adapt to FLC
concentrations higher than its minimal inhibitory concentration
(MIC) by becoming aneuploid [35]. Chromosome 1 (Chr1) disomy
was a common signature of FLC
R strains, and two of the genes
resident on this chromosome were shown to be important for FLC
resistance: ERG11 (cytochrome P450 lanosterol 14a-demethylase),
which is the target of FLC, and AFR1 (antifungal resistance 1,
[36]), which is the major ATP binding cassette (ABC) transporter
of azoles in C. neoformans [35]. Therefore, we determined the copy
number of Chr1 in several FLC
R colonies isolated from
independent Etest assays (Table 3). We used a quantitative
polymerase chain reaction (qPCR) assay and three probes
distributed along Chr1: ERG11, ACT1, and AFR1 (Figure S3). A
subset of the colonies was karyotyped by array comparative
genomic hybridization (aCGH; Figure 2B-E and Figure S4). DNA
content analyses by flow cytometry indicate that all strains
described in Table 3 are haploid or near haploid (n+1) (data not
shown).
In the wild-type H99 background, four out of eight colonies
(50%) isolated from Etest halos had MICs greater than 48 mg/ml
for FLC and also had Chr1 disomy (Table 3, Figure 2B). The four
colonies that presented MICs less than 48 mg/ml were euploid
(Table 3). Resistant colonies isolated from a second round of Etests
presented higher MICs than the original four strains, and in all
cases Chr1 was duplicated (Table 3, Figure 2C). Notably, all aif1
FLC
R colonies (100%) isolated directly from Etest experiments
became completely resistant to FLC and also had whole or partial
Chr1 disomy (Table 3). From our aCGH analysis, it was clear that
some FLC
R colonies in the aif1 background had whole or partial
chromosome duplications in addition to Chr1, which were not
observed for the H99 wild-type background (Figure 2D-E, Table 3,
Figure S4).
A complemented strain, in which the AIF1 gene with its native
promoter and terminator was ectopically integrated into the
genome, behaved like the wild-type strain in Etest assays
(Figure 2A) and FLC fluctuation analysis (Table 2). Only two
out of ten colonies (25%) isolated from Etest halos had MICs
greater than 48 mg/ml for FLC and also had Chr1 disomy
(Table 3), while the remaining colonies were euploid. In
conclusion, aneuploidy and FLC resistance emerge at higher
frequency in the absence of Aif1.
Aneuploid isolates are stable and do not show decreased
stress resistance
FLC resistance acquired through Chr1 disomy was reported to
be lost during passage in drug-free media, and the clones returned
to their original euploid state [33,35]. To test if FLC
R aneuploid
isolates would lose their adaptive phenotype upon removal of the
selective pressure imposed by the drug, we chose to test two
isolates with Chr1 disomy [n+(1)] and FLC resistance in wild-type
H99, the aif1 mutant, and the aif1+AIF1 complemented strain.
Upon growth in FLC-free liquid medium for about 20
generations, the isolates in the wild-type (CPS106 and CPS149)
and complemented (CPS178 and CPS179) backgrounds returned
to the native heteroresistant phenotype (Table 4). However, the
isolates in the aif1 background (CPS18 and CPS24) did not lose
the FLC resistance phenotype during nonselective growth
(Table 4). These results indicate that the aneuploid FLC
R cells
are stabilized and tolerated in the absence of Aif1.
Aneuploid S. cerevisiae strains bearing an extra copy of various
chromosomes displayed decreased resistance to stress, such as
increased sensitivity to high temperatures and to protein synthesis
inhibitors [37]. We tested whether the FLC
R aneuploid isolates
that we isolated had a similar phenotype. As shown in Figure 3A,
none of the tested aneuploid strains (including isolates of different
strain backgrounds and containing various chromosomal ampli-
fications) showed increased sensitivity to high temperatures or to
the protein synthesis inhibitor rapamycin. The only difference that
we noticed in the aneuploid strains compared with euploid strains
was the presence of elongated and larger cells (data not shown),
which was also observed by Sionov et al. [35]. Because there was
no difference between aneuploid strains in the AIF1 and aif1
backgrounds, we did not further investigate this phenotypic
characteristic.
Increased aneuploidy in aif1 mutant is not due to a
defect in mitotic checkpoint
We considered that the increased frequency of FLC
R subpop-
ulations in the aif1 mutant could be explained by two possible
mechanisms. First, it is possible that Aif1-mediated ALCD would
eliminate aneuploid cells from the population, and in the absence
of Aif1, aneuploid cells persist within the population and emerge as
FLC
R isolates. Another hypothesis is that Aif1 has non-apoptotic
functions related to proper chromosomal segregation.
Table 1. Minimal inhibitory concentration (MIC, mg/ml) found
in Etest assays.
Strain FLC (mg/ml) AMB (mg/ml)
H99 6 0.125
CPS3 (aif1::NAT) 16* 0.125
CPS70 (aif1::HYG) 16* 0.125
CPS174 (aif1::NAT AIF1-NEO) 6 0.125
YPH104 (mca1 mca2) 24 0.19
CPS89 (aif1 mca1 mca2) 8* 0.19
HC-4** 4 0.75
HC-6** 16 0.19
HC-9** 12 0.25
RCT 50** 32 0.125
RCT 52** .256 0.125
RCT 55** 48 0.19
RCT 17** 16* 0.125
CPS175 (RCT 17 AIF1-NEO) 16 0.125
*Rapid acquisition of resistance to FLC.
**Initial cultures of clinical isolates used for Etest assays were obtained directly
from frozen CSF samples of patients that had not yet been treated with any
antifungal drug (HC isolates from Duke patients; RCT isolates from patients in
South Africa).
doi:10.1371/journal.ppat.1002364.t001
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examined its sensitivity to benomyl. In S. cerevisiae, hypersensitivity
to the microtubule-destabilizing drug benomyl of ‘‘budding
uninhibited by benzimidazole’’ (bub) mutants correlates with their
mitotic checkpoint defect [38,39]. As shown in Figure 3B, the aif1
mutant did not exhibit sensitivity to benomyl. To eliminate the
possibility that benomyl is simply not taken up by C. neoformans,w e
deleted the gene CNAG_03184, which was the first reciprocal
BLASTp hit with S. cerevisiae Bub1, in the H99 background. As
expected, the bub1 mutant showed an increased sensitivity to
benomyl, indicating that this drug is active in C. neoformans.I n
conclusion, because aif1 has an intact mitotic spindle checkpoint,
we propose that Aif1-mediated ALCD eliminates aneuploid cells
from the population.
Aneuploid isolates are resistant to fluconazole treatment
in vivo
C. neoformans strains with FLC resistance levels greater than
32 mg/ml were previously reported to have higher virulence in
mice [33]. To test if that would also be the case for isolates in the
aif1 mutant background, we tested the virulence of two strains
completely resistant to FLC using an inhalation murine model of
cryptococcosis. Mice were intranasally infected with the indicated
strains, and their survival was monitored and plotted against time.
The aif1 mutant has a virulence level similar to wild-type (see
below). As shown in Figure 3C, FLC
R strains CPS18 [FLC
R256
n+(1)] and CPS24 [FLC
R256 n+dup(1)(3)] showed similar virulence
to the H99 strain (untreated cohort of animals; p-values of 0.5739
and 0.5252, respectively).
Next, we tested the efficacy of antifungal therapy when infection
is caused by FLC
R strains. Treatment with 20 mg/kg/day of FLC
was initiated 24 hours after infection and was continued for 14
days, as described by [33]. As shown in Figure S5, treatment with
20 mg/kg/day of FLC for 14 days modestly prolonged the
survival of mice inoculated with wild-type H99 (p-value of 0.0043)
and aif1 mutant (p-value of 0.0023) strains, but it did not prolong
the survival of cohorts inoculated with the CPS18 (p-value of
0.1443) and CPS24 (p-value of 0.2237) resistant isolates. In a
second set of experiments, we evaluated the efficacy of a higher
FLC dosage, and animals received 100 mg/kg/day of FLC,
without treatment interruption. All mice inoculated with wild-type
H99 and aif1 mutant strains and treated with 100 mg/kg/day of
FLC survived for 60 days (p-values ,0.0001). On the other hand,
while treatment with 100 mg/kg/day of FLC prolonged the
survival of mice inoculated with the CPS18 and CPS24 resistant
isolates (p-values ,0.0001), 100% mortality was observed in these
cohorts (Figure 3C).
Additionally, we examined if resistant strains would appear
during FLC treatment and if aneuploidy would be stable with in
vivo passage. We randomly selected three mice treated with
100 mg/kg/day of FLC for each strain. For CPS18 and CPS24
cohorts, the mice were sampled post-mortem between 30 and 35
days post-infection. For H99 and aif1 cohorts, we used
asymptomatic mice sacrificed on day 60, when the experiment
was terminated. Colonies recovered on YPD medium from lungs
and brains were tested for resistance to FLC. About 8% of wild-
type and 29% of aif1 colonies developed FLC
R in vivo during
treatment, while more than 96% of CPS18 and CPS24 colonies
retained their initial FLC resistance acquired in vitro (Figure 4A).
The aCGH analysis of a wild-type H99 FLC
R colony (CPS129)
selected randomly showed that this isolate acquired Chr1 disomy
(Figure 4B). Ploidy analysis by FACS indicated that CPS129 was
diploid [2n+(1), data not shown]. Increased ploidy has recently
been described in C. neoformans to be associated with the formation
of giant yeast cells in infected animals [40,41]. The aCGH analysis
of an aif1 FLC
R colony (CPS134) showed duplication of
chromosomes 1, 4, and 6 (Figure 4C), while FLC
R colonies in
the CPS18 (CPS145) and CPS24 (CPS146) backgrounds main-
tained their initial state of aneuploidy (Figure 4D and 4E). These
in vivo results can be correlated to our in vitro experiments
(Table 2 and Table 4), but it is clear that the interaction of C.
neoformans with the murine host environment promotes genomic
plasticity, which serves to generate new phenotypic adaptations in
this pathogen with disease management consequences.
Clinical isolate RCT 17 shows increased fluconazole
resistance associated with aneuploidy and reduced AIF1
expression
To evaluate and validate if defects in the apoptotic pathway of
C. neoformans have any impact on azole resistance in the human
clinical setting, we tested the susceptibility to FLC of seven clinical
isolates taken directly from frozen cerebrospinal fluid (CSF) of
individual patients with cryptococcal meningitis. Microevolution
and phenotypic variability of C. neoformans isolates occurs in the
laboratory through multiple in vitro passages (reviewed by [42–
44]). Therefore, an important factor considered in our experi-
mental design when testing clinical isolates was the use of colonies
isolated directly from CSF. We also targeted initial clinical isolates,
collected before the commencement of antifungal therapy. It is
important to note that the RCT isolates originated from South
Africa, an HIV endemic area, and FLC is sometimes used as a
prophylactic antifungal treatment in HIV/AIDS patients, and
Figure 2. Disruption of apoptosis-inducing factor stimulates the selection of fluconazole resistant subpopulations. A. Etest strip
assays showing that deletion of aif1 increases the frequency of the intrinsic adaptive fluconazole heteroresistant phenotype of serotype A wild-type
strain H99. B. aCGH analysis of a fluconazole-resistant colony isolated from the H99 wild-type background (CPS51) on an Etest assay showing a higher
MIC (32 mg/ml) but no alteration in chromosome numbers. C. aCGH analysis of a FLC
R clone CPS106, isolated from the CPS51 background on Etest
assay showing complete resistance to FLC (MIC .256 mg/ml) and Chr1 disomy. D-E. Clones isolated from the aif1 mutant immediately show
complete resistance to FLC (MIC .256 mg/ml) and multiple whole or partial chromosome duplications. Clone CPS18 is disomic for Chr1 (D) and clone
CPS24 has segmental duplications of chromosomes 1 and 3 (E). Vertical bars in red indicate amplifications, and in green deletions, that are statistically
significant. Vertical bars in gray indicate no DNA copy number alteration or amplifications or deletions that did not meet the statistical settings.
doi:10.1371/journal.ppat.1002364.g002
Table 2. FLC resistance rates.
Strain FLC
R rate x 10
-6 (95% CI*) FLC
R rate relative to WT
WT 4.3 (3.0–6.6) 1
aif1 22.2 (17.4–27.5) 5.2
aif1+AIF1 4.5 (2.8–6.4) 1.1
RCT 17 82.1 (62.7–99.8) 19.3
RCT 17+AIF1 14.7 (11.0–17.2) 3.4
*Confidence interval.
doi:10.1371/journal.ppat.1002364.t002
Apoptosis in Cryptococcus neoformans
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these isolates.
As shown in Table 1, the susceptibility to FLC of the seven
direct clinical isolates varied, with MICs ranging from 4 to
.256 mg/ml. Specifically, isolate RCT 17 showed FLC
R colonies
within the zone of inhibition around the FLC strip in Etest assays,
similar to the aif1 mutants (Figure 5A). Moreover, such colonies
were completely resistant to FLC and exhibit Chr1 disomy
(Figure 5B, and Table 3). RCT 17 showed a FLC resistance rate
that was about 20 times higher than H99 and 4 times higher than
the aif1 strain (Table 2). The FLC
R isolates CPS104 and CPS157
in the RCT 17 background did not revert to FLC sensitivity
during growth on FLC-free medium for 20 generations (Table 4),
showing that aneuploid FLC
R cells are stable in the RCT17
background, as was observed for the aif1 mutant.
Given the similarities between the clinical isolate RCT 17 and
the aif1 mutant, we hypothesized that the AIF1 gene might be
defective in this clinical isolate. Quantitative RT-PCR (qRT-PCR)
revealed that AIF1 expression is approximately 80% reduced in
the RCT 17 isolate compared to the H99 strain (Figure 5C). DNA
sequence analysis determined the presence of five nucleotide
polymorphisms in the AIF1 promoter and coding sequence from
RCT 17 compared to the H99 (data not shown). Of note, the
primer pair used for the qRT-PCR was designed to encompass the
boundaries of exons 1 and 2, a region that has no polymorphisms
in the RCT 17 isolate. Complementation of the RCT 17 strain
with the AIF1 gene and its native promoter and terminator
restored normal AIF1 expression levels (Figure 5C), reduced the
FLC heteroresistance rate (Figure S6A and Table 2), and reversed
the stability of the aneuploid Chr1 in the absence of FLC (Table 4),
indicating that low AIF1 expression levels are responsible for the
RCT 17 aif1-like phenotypes.
Additionally, we evaluated AIF1 expression in two other clinical
isolates from the USA that were reported to be disomic for other
chromosomes besides Chr1. Isolates HC-4 and HC-6 show partial
duplication for chromosomes 9 and 6, respectively (Figure 5D and
5E and Hu and Kronstad et al., manuscript in preparation). AIF1
expression is also reduced in isolates HC-4 and HC-6 (Figure 5C),
Table 3. Summary of ploidy of FLC
R clones.
Background* Strain
FLC MIC
(mg/ml) Genotype** Method
H99 FLC
R6 CPS51 32 n aCGH
H99 FLC
R6 CPS52 16 n aCGH
H99 FLC
R6 CPS53 64 n+(1) qPCR
H99 FLC
R6 CPS105 32 n qPCR
H99 FLC
R6 CPS137 24 n qPCR
H99 FLC
R6 CPS151 48 n+(1) qPCR
H99 FLC
R6 CPS154 48 n+(1) aCGH
H99 FLC
R6 CPS155 64 n+(1) qPCR
CPS51 CPS106 .256 n+(1) aCGH
CPS51 CPS107 .256 n+(1) qPCR
CPS52 CPS108 192 n+(1) qPCR
CPS52 CPS109 192 n+(1) qPCR
CPS105 CPS147 .256 n+(1) qPCR
CPS108 CPS148 .256 n+(1) qPCR
CPS109 CPS149 .256 n+(1) aCGH
aif1::NAT FLC
R16 CPS18 .256 n+(1) aCGH
aif1::NAT FLC
R16 CPS21 .256 n+(1) qPCR
aif1::NAT FLC
R16 CPS24 .256 n+dup(1)(3) aCGH
aif1::NAT FLC
R16 CPS26 .256 n+(1) qPCR
aif1::NAT FLC
R16 CPS28 .256 n+(1) qPCR
aif1::NAT FLC
R16 CPS35 192 n+(1) qPCR
aif1::NAT FLC
R16 CPS37 .256 n+(1) aCGH
aif1::NAT FLC
R16 CPS48 .256 n+(1)(4) aCGH
aif1::NAT FLC
R16 CPS49 .256 n+(1) qPCR
aif1::HYG FLC
R16 CPS110 .256 n+(1) aCGH
aif1::HYG FLC
R16 CPS111 .256 n+(1) aCGH
aif1::HYG FLC
R16 CPS114 .256 n+(1) qPCR
aif1::HYG FLC
R16 CPS126 .256 n+(1) qPCR
aif1::HYG FLC
R16 CPS128 .256 n+(1) qPCR
aif1::HYG FLC
R16 CPS135 .256 n+(1) qPCR
aif1::NAT AIF1-NEO FLC
R6 CPS177 16 n aCGH
aif1::NAT AIF1-NEO FLC
R6 CPS178 48 n+(1) aCGH
aif1::NAT AIF1-NEO FLC
R6 CPS179 48 n+(1) aCGH
aif1::NAT AIF1-NEO FLC
R6 CPS183 8 n qPCR
aif1::NAT AIF1-NEO FLC
R6 CPS184 8 n qPCR
aif1::NAT AIF1-NEO FLC
R6 CPS185 24 n qPCR
aif1::NAT AIF1-NEO FLC
R6 CPS189 16 n qPCR
aif1::NAT AIF1-NEO FLC
R6 CPS190 8 n qPCR
aif1::NAT AIF1-NEO FLC
R6 CPS193 16 n qPCR
aif1::NAT AIF1-NEO FLC
R6 CPS194 32 n qPCR
RCT 17 FLC
R16 CPS104 .256 n+(1) aCGH
RCT 17 FLC
R16 CPS136 64 n+(1) qPCR
RCT 17 FLC
R16 CPS141 .256 n+(1) qPCR
RCT 17 FLC
R16 CPS142 .256 n+(1) qPCR
RCT 17 FLC
R16 CPS152 .256 n+(1) aCGH
RCT 17 FLC
R16 CPS153 .256 n+(1) qPCR
RCT 17 FLC
R16 CPS157 .256 n+(1) aCGH
RCT 17 FLC
R16 CPS158 .256 n+(1) qPCR
Background* Strain
FLC MIC
(mg/ml) Genotype** Method
RCT 17 FLC
R16 CPS159 .256 n+(1) qPCR
RCT 17 FLC
R16 CPS160 192 n+(1) qPCR
RCT 17 AIF1-NEO FLC
R16 CPS180 32 n aCGH
RCT 17 AIF1-NEO FLC
R16 CPS181 96 n+(1) aCGH
RCT 17 AIF1-NEO FLC
R16 CPS182 64 n+(1) aCGH
RCT 17 AIF1-NEO FLC
R16 CPS186 32 n qPCR
RCT 17 AIF1-NEO FLC
R16 CPS187 16 n qPCR
RCT 17 AIF1-NEO FLC
R16 CPS188 32 n qPCR
RCT 17 AIF1-NEO FLC
R16 CPS191 16 n qPCR
RCT 17 AIF1-NEO FLC
R16 CPS192 32 n qPCR
RCT 17 AIF1-NEO FLC
R16 CPS195 32 n qPCR
RCT 17 AIF1-NEO FLC
R16 CPS196 32 n qPCR
Data provided in Figures 2, 5, S3B, and S4.
*FLC
R corresponds to MIC indicated in Table 1.
**Numbers in parentheses represent disomic chromosomes; segmental
duplications are indicated as ‘‘dup’’.
doi:10.1371/journal.ppat.1002364.t003
Table 3. Cont.
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cryptococcal cells under strong selective drug pressure and might
be a novel aneuploidy-tolerating mechanism.
Apoptotic pathways are required for sporulation during
mating in C. neoformans
During the genetic manipulations of our apoptotic mutants, we
noticed that they displayed defective mating phenotypes. Mating
in C. neoformans is initiated by fusion between a and a cells to
produce dikaryotic filaments, and the process culminates in the
formation of basidia decorated with four spore chains. Spores
formed by mating represent infectious propagules for C. neoformans.
Mating filament production was reduced but not abolished when
aif1, mca1 mca2, and aif1 mca1 mca2 independent mutants of
opposite mating types were subjected to bilateral mutant crosses
(Figure S7A). In unilateral crosses (mutant 6wild-type), the aif1,
mca1 mca2, and aif1 mca1 mca2 mutants had delayed formation of
filaments compared with a wild-type cross, but were still fertile
(data not shown). Bilateral crosses of the aif1 mca1 mca2 triple
mutant showed more severe defects in filamentation, indicating
that both Aif1 and the metacaspases have a role in C. neoformans
mating. In confrontation assays between the aif1, mca1 mca2, and
aif1 mca1 mca2 mutants and a crg1 mutant strain, which is
hypersensitive to mating pheromone and produces abundant
conjugation tubes when confronted with wild-type cells of the
opposite mating type [45], no conjugation tubes were produced,
indicating a decrease in pheromone secretion by the aif1, mca1
mca2 and aif1 mca1 mca2 mutants (Figure S7B).
Decreased hyphal growth during mating can be a result of
defective fusion between a and a cells. To determine if this was the
case in the aif1 and metacaspase mutants, cell fusion assays using
opposite mating type strains with dominant genetic markers in
bilateral crosses were conducted. The formation of double-
resistant diploids by cell fusion was quantified after 48 h of
incubation on mating medium. Many diploid isolates were
produced from the wild-type control cross compared with the
bilateral mutant crosses (Figure S8). We also examined fusion in
unilateral crosses between the mca1 mca2 mutant and wild-type
strains. The number of diploid isolates produced from these
crosses was considerably lower than those with wild-type strains,
demonstrating that one copy of each metacaspase gene is not
sufficient for fusion (Figure S8). Hence, Aif1 and the metacaspases
are required for the cell fusion step of mating in C. neoformans.
Additionally, a significant reduction in basidiospore production
was observed in bilateral mutant crosses (Figure 6A). The aif1 and
mca1 mca2 mutants produce defective basidia with aberrant spore
chains (Figure 6A-D), although these strains were not sterile, and
we were able to isolate recombinant spores in which the mutations
were recovered in the opposite mating type. Sporulation in the aif1
mca1 mca2 bilateral mutant cross was impaired and most basidia
produced few spores, in contrast to the four long spore chains
observed in a wild-type cross (Figure 6). Basidiospore production
defects were also observed in unilateral crosses between aif1 mca1
mca2 mutant and wild-type strains (data not shown). We conclude
that ALCD is required for the proper sporulation of C. neoformans.
The aif1 and metacaspase mutants show decreased
competitive fitness but have no defects in virulence
Apoptosis plays an essential role in maintaining homeostasis in
multicellular organisms by eliminating permanently damaged
cells. In the unicellular yeast S. cerevisiae, ALCD has been proposed
to eliminate the less fit individuals from a monoclonal population
of cells, thereby improving the chance of survival of the fitter
clones in the genetic pool [46,47]. To determine whether the
apoptotic pathways are relevant to the ability of C. neoformans
populations to compete for resources in a common environment,
the fitness of apoptotic null mutants was measured in pair-wise
growth competition assays with wild-type. The same amount of
cells from wild-type and apoptotic null mutant strains grown to
exponential phase were mixed in liquid YPD medium and
incubated at 30uC with agitation. Each strain was identified based
on differing genetic markers, including a control sample using two
wild-type strains. To reduce cell fusion and mating during the
experiment, all strains used were of the a mating type. Aliquots of
each culture were taken at the indicated times and plated on
selective media to calculate the survival ratios. As shown in
Figure 7A, the apoptotic defective mutants were outcompeted by
the wild-type cells. Because the aif1, mca1 mca2, and aif1 mca1 mca2
mutants had similar division rates as wild-type in liquid YPD
medium at 30uC during solo culture (Figure S9), we eliminated the
possibility that the wild-type cells were simply more fit to begin
with, and thus concluded that wild-type cells exhibit enhanced
fitness during co-culture with apoptotic mutant cells.
To determine whether the apoptotic null mutants had any
growth defect in the host environment, we performed virulence
assays in a murine inhalation model of cryptococcosis. Mice were
intranasally infected with wild-type and mutant strains, and their
survival was monitored and plotted against time (Figure 7B).
Compared to the wild-type strain, the apoptotic defective mutants
showed no significant difference in virulence (Figure 7B), fungal
burden, or organ dissemination pattern (data not shown).
Therefore, inactivation of ALCD had no apparent impact on
the virulence of C. neoformans in these tested conditions.
Discussion
Apoptosis was long thought to be restricted to metazoans, but a
growing body of evidence has established that it appears to be a
common feature of diverse organisms. During the past decade,
ALCD has been described in the majority of phylogenetic lineages
including eubacteria, protists, plants, and fungi [11,48,49]. While
the body of evidence supporting apoptotic fungal cell death is
growing, the molecular mechanisms underlying fungal apoptotic
pathways and their physiological relevance are poorly understood.
Here, we show that Aif1 and metacaspases are independently
Table 4. Reversion rates of resistance to FLC after 20
generations
Strain Background FLC
R reversion rate (%)*
CPS106 WT 96.066.9
CPS149 WT 96.362.5
CPS18 aif1 9.065.9
CPS24 aif1 3.060.8
CPS178 aif1+AIF1 81.762.9
CPS179 aif1+AIF1 76.363.5
CPS104 RCT 17 7.764.7
CPS157 RCT 17 0.060.0
CPS181 RCT 17+AIF1 75.761.3
CPS182 RCT 17+AIF1 72.364.5
*Reversion rate was calculated based on three independent experiments and
values represent averages 6 standard deviation.
doi:10.1371/journal.ppat.1002364.t004
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both Aif1 and the metacaspases are important for sexual
development, only Aif1 is necessary for ploidy maintenance
(Figure 8, further discussed below).
We found that the aif1, mca1 mca2, and aif1 mca1 mca2 of C.
neoformans have impaired sexual reproduction with a consequent
reduction in formation of spores as infectious propagules (Figure 6).
Similarly, the formation of ascospores in Podospora anserina was
severely impaired in mutants with defective metacaspases [50] and
the apoptosis-inducing factor homolog Amid2 [51]. Apoptotic
markers, such as positive TUNEL reactions, were observed during
sporulation in the basidiomycete Coprinopsis cinerea [52]. Further-
more, analysis of sporulation-defective mutants revealed the
existence of a state in which, although meiosis was successfully
completed, basidiospore formation was impaired due to lack of
apoptosis [52].
Wild-type C. neoformans cells were observed to outgrow the aif1,
mca1 mca2, and aif1 mca1 mca2 mutants in competitive growth
assays. Likewise, in S. cerevisiae, the metacaspase yca1 and aif1
deletion mutants also show a decreased competitive fitness
phenotype [47,53]. ALCD was proposed to contribute to the
fitness and adaptability of yeast populations by removing damaged
or less fit clones. The fact that the aif1, mca1 mca2, and aif1 mca1
mca2 mutants cannot outcompete wild-type cells for resources in a
common environment might explain, at least partially, why
natural selection has preserved the apoptotic pathways in
unicellular yeasts. It is also reasonable to consider that yeast
apoptotic proteins may also participate in vital non-death
functions. In support of this hypothesis, Yca1 was shown to have
non-death roles in the timing of the yeast cell cycle [54] and the
removal of insoluble protein aggregates [55].
It is interesting to highlight that the evolutionary implications of
removing ALCD depend on selective pressure. For example,
under conditions to which wild-type cells are well adapted, the aif1
mutant is not able to outcompete for environmental resources. On
the other hand, under a strong selective pressure such as drug
treatment, AIF1 inactivation promotes the stabilization of
aneuploidy and thus rapid adaptation to the stress of FLC. Such
observations can be compared to the known roles of apoptosis in
multicellular eukaryotes; while apoptosis effectively promotes
tissue homeostasis, its inactivation promotes tumorigenesis and
the emergence of drug-resistant cancer cells.
Links between Aif1, aneuploidy, and the emergence of
drug resistance
Alteration in gene copy number is a major mechanism for
environmental adaptation of asexual yeast populations. In S.
cerevisiae, aneuploidy was shown to confer improved growth and
fitness advantages under stressful conditions [37,56,57]. Aneuploi-
dy was also associated with FLC resistance in Candida species [58–
61]. In C. albicans, a specific segmental aneuploidy, isochromosome
5L [i(5L)], is commonly found in FLC
R isolates, and the loss of
i(5L) is correlated with reduced FLC resistance [58]. Gain of i(5L),
which is comprised of two identical chromosome 5 left arms
flanking a centromere, amplifies two genes that contribute
additively and independently to FLC resistance: ERG11 (the
target of FLC) and TAC1 (a transcription factor that activates
expression of the drug efflux pumps CDR1 and CDR2 [59]).
The acquisition of aneuploidy was recently reported in strains of
C. neoformans that display heteroresistance to FLC [35]. Hetero-
resistance in C. neoformans is defined as heterogeneous FLC
susceptibility within a population with resistant subpopulations
being able to adapt to higher concentrations of the drug in a
stepwise and reversible manner [31–33]. Heteroresistance is
considered different from trailing phenomena or incomplete
growth inhibition by azoles observed in Candida species. Trailing
growth can cause the MICs of azoles for some isolates to be low
(susceptible) after 24 h of growth but much higher (resistant) after
48 h [62]. The relevance of such discordant interpretive categories
at the two time points is as yet unclear, but current evidence
suggests that the lower MIC correlates most closely with the
outcome in vivo [62]. Bacterial populations were reported to
produce persister cells that neither grow nor die in the presence of
microbicidal antibiotics. Persisters are largely responsible for high
levels of biofilm tolerance to antimicrobials, but do not exhibit an
increased MIC. C. albicans persister cells that survived killing by
AMB were detected only in biofilms and not in exponentially
growing or stationary-phase planktonic populations [63].
Even though we used Etest assays to isolate FLC
R colonies in
this study, our results support previous findings in which the H99
strain exposed to FLC in liquid cultures became resistant in a step-
wise pattern to increasing concentrations of the drug after
acquisition of specific chromosomal duplications [33,35]. In our
experiments, Chr1 disomy was observed in H99 derivatives that
became resistant to more than 48 mg/ml of FLC and was more
common on second Etest passages, while disruption of aif1
stimulated the selection of completely FLC
R (MIC .256 mg/ml)
subpopulations. Amplification of chromosomes other than Chr1,
particularly Chr4, was observed in aif1 derivatives, but not in the
H99 or AIF1 complemented derivatives isolated in Etest
experiments (Table 3). In the aif1 derivatives, segmental
chromosomal duplications were also observed; isolate CPS24
had the left arm of Chr1 duplicated, which harbors ERG11, and
the end of the right arm of chromosome 3 (Figure 2E and Figure
S3A). C. gattii isolates resistant to 64 mg/ml of FLC showed
different patterns of chromosomal amplifications, including
disomy and segmental duplication of several chromosomes besides
Chr1 [64]. Clinical isolate RCT 52 had a FLC MIC .256 mg/ml
(Table 1) but did not show any chromosomal amplification (data
not shown), indicating that not all FLC
R isolates are aneuploid.
These findings emphasize the existence of FLC resistance
mechanisms that are independent of Chr1 disomy.
After about 20 generations of non-selective growth, more than
90% of FLC
R colonies in the H99 background and 75% in the
complemented strain returned to being FLC sensitive, while less
than 10% in the aif1 background lost resistance to FLC upon
removal of the drug pressure (Table 4). The lack of benomyl
sensitivity in the aif1 mutant excludes the possibility that the
observed increased aneuploidy in this strain is a result of a
defective mitotic spindle checkpoint. Our results show that the lack
of a functional Aif1 was able to stabilize the aneuploid state
selected by FLC treatment, and we propose that aif1 is an
aneuploidy-tolerating mutation in C. neoformans.
Figure 3. Fluconazole resistant aneuploid clones are stable and virulent. A. Aneuploid FLC
R clones are not temperature sensitive or more
sensitive to the inhibitor rapamycin. Strains from the top: CPS3, CPS18, CPS24, CPS37, CPS48, H99, CPS106, RCT 17, CPS104, and KK8 (used as a control
for temperature-sensitivity). B. The aif1 mutant has a functional mitotic checkpoint in response to the indicated concentrations of the microtubule-
destabilizing drug benomyl. C. FLC
R clones are more resistant to FLC treatment than wild-type and aif1 mutants in murine cryptococcal infection
model. Mice were infected intranasally with strains H99, CPS3, CPS18, and CPS24 and treated with 100 mg/kg/day of FLC.
doi:10.1371/journal.ppat.1002364.g003
Apoptosis in Cryptococcus neoformans
PLoS Pathogens | www.plospathogens.org 10 November 2011 | Volume 7 | Issue 11 | e1002364Apoptosis in Cryptococcus neoformans
PLoS Pathogens | www.plospathogens.org 11 November 2011 | Volume 7 | Issue 11 | e1002364Torres et al. [56] described the existence of aneuploidy-
tolerating mutations in yeast, such as the deubiquitinating enzyme
Ubp6, which improves growth rates in aneuploid yeast strains by
attenuating the protein stoichiometry imbalances caused by
chromosomal amplifications. We did not observe that FLC
R
aneuploid strains display an increased sensitivity to stresses, such as
reported in S. cerevisiae by Torres et al. [37]. The results shown in
Figure 3A suggest that aneuploidy does not inevitably result in
decreased resistance to stress, and are in agreement with a recent
study by Pavelka et al. [57], which showed that aneuploidy directly
confers phenotypic variation that can result in a growth advantage
under stress conditions that are suboptimal for euploid cells. The
conflicting results in S. cerevisiae were explained by the different
methods used to generate the aneuploid strains; while Torres et al.
[37] constructed their aneuploid strains through selection with a
combination of drug and nutrient markers, Pavelka et al. [57]
generated aneuploid strains through random meiotic segregation,
suggesting an impact of both karyotype and continuous selection
with drugs and nutrient markers in the phenotypic variation
conferred by aneuploidy [57]. Interestingly, as in Pavelka et al.
[57], we observed that certain aneuploid strains were able to grow
better in the presence of drugs such FLC and rapamycin (strain
WT FLC
R256, Figure 3A).
Rancati et al. [65] reported that S. cerevisiae cells lacking MYO1,
which encodes the only myosin-II normally required for
cytokinesis, rapidly acquired aneuploidy that led to specific
changes in the transcriptome that restored growth and cytokinesis.
Therefore, one possibility is that aif1 mutants have more stable
Chr1 aneuploidy because genes present on Chr1L might
complement Aif1 functions. It should be noted that no growth
defect (besides the decreased competitiveness with wild-type) was
observed for aif1 mutant strains, and that Chr1 aneuploidy did not
appear to improve aif1 mutant strains growth. We speculate that
apoptosis orchestrated by Aif1 eliminates aneuploid cells from the
population.
Why didn’t the metacaspase mutants have an increased rate of
aneuploidy and consequent resistance to FLC? Based on the fact
that Aif1 and the metacaspases are independently required for
apoptosis in C. neoformans, it is possible to speculate that the
elimination of aneuploid cells from the population is regulated by a
caspase-independent apoptotic pathway. In yeast, the Yca1
caspase-like protease participates in approximately 40% of the
investigated cell death scenarios, while Aif1 and endonuclase G
execute caspase-independent cell death [66]. It is also possible that
ploidy maintenance is a non-death function of Aif1.
FLC
R colonies isolated from the H99 and aif1 strains during our
in vivo experiments showed more complex patterns of ploidy
increase and amplifications (Figure 4B and 4C). The interaction of
C. neoformans with mammalian hosts has been shown to promote
genomic plasticity in this pathogen (reviewed by [67]). Compar-
ative hybridization studies characterized disomy for chromosome
13 in two independent clinical isolates [68]. Additionally, the
formation of giant cells with diameters up to 100 mm was observed
during murine cryptococcal infection [40,41]. These giant yeast
cells were found mainly in lung tissue and were polyploid and
uninucleate, suggesting that they arise from DNA endoreplication
without concomitant cell division. It will be interesting to
investigate if ALCD is also important in ploidy increase and the
formation of giant yeast cells. In preliminary analysis of FLC Etests
using a diploid wild-type strain, we did not observe an increase in
heteroresistance while a diploid aif1 strain still showed increased
heteroresistance (Figure S6B).
In our in vivo virulence experiments, we evaluated the efficacy
of FLC therapy for wild-type and FLC
R strains using a murine
model of cryptococcal meningitis. Treatment with 100 mg/kg/
day of FLC had antifungal activity against H99 and aif1 strains
(but did not clear infection in the brains of the animals) and
doubled the survival time of mice infected with FLC
R strains.
Pharmacodynamic studies, using the area under the concentra-
tion-time curve (AUC), showed that FLC therapy in doses of
100 mg/kg/day given to mice mimics doses of 400 mg/day given
to humans [69]. Therefore, the use of higher dosages of FLC
might be beneficial in patients, and may help to reduce morbidity
and mortality due to cryptococcal meningitis in Africa and other
resource-limited regions.
We found that RCT 17, one of seven direct clinical isolates, had
increased heteroresistance to FLC, similar to the heteroresistance
observed in the aif1 mutants (Table 1, Figure 5A). Furthermore,
FLC
R colonies isolated from the RCT 17 background also became
completely resistant to FLC through the acquisition of aneuploidy
(Figure 5B, and Table 3) and did not revert to being FLC-sensitive
during growth on FLC-free medium for 20 generations (Table 4).
AIF1 expression was shown to be downregulated in RCT 17 by
qRT-PCR (Figure 5C), and complementation with AIF1 with its
native promoter and terminator recovered normal expression
levels and reverted the increased heteroresistance to FLC (Table 2
and Table 3). AIF1 expression was also reduced in the HC-4 and
HC-6 clinical isolates (Figure 5C), which show disomies for
chromosomes other than Chr1 and are not resistant to FLC
(Table 1, Figure 5D and 5E). Therefore, we propose that the
inactivation of AIF1 is a novel aneuploidy-tolerating mechanism in
fungi that might not be restricted to cells under strong selective
FLC drug pressure. Future investigations will test the mechanisms
that result in AIF1 downregulation.
Our results suggest that triggering fungal ALCD should be
further investigated as a new antifungal approach. Potential
antifungal targets include those that can help another antifungal
agent by blocking resistance mechanism(s) in vivo used by the
microorganisms. This principle has previously been demonstrated
by beta-lactamase inhibitors in antibacterial combination drugs
[70] but has yet to be applied in therapies including new antifungal
agents. An AIF1-inducing agent could have a profound effect on
the ability of C. neoformans to become resistant in vivo to FLC, and
the addition of such inducer to the antifungal regimen could make
FLC fungicidal in the host.
In conclusion, our results bring to light the importance of the
Aif1 in maintaining the euploidy of yeast populations, possibly
through the elimination of aneuploid cells via apoptosis.
Inactivation of AIF1 might increase genomic plasticity of C.
neoformans during infection and promote the generation of
phenotypic adaptations such as new virulence traits and antifungal
drug resistance.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with The
National Research Council’s Guide for the Care and Use of
Figure 4. Strains recovered from treated mice are fluconazole resistant and aneuploid. A. Percentage of FLC
R colonies isolated from lungs
and brains of 3 mice treated with FLC. *, ** and *** indicates significance at p,0.05, 0.01 and 0.001, respectively. B-E. aCGH analysis of FLC
R colonies
recovered from mice infected intranasally with strains H99 (B, CPS129), CPS3 (C, CPS134), CPS18 (D, CPS145), and CPS24 (E, CPS146).
doi:10.1371/journal.ppat.1002364.g004
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Care and Use of Laboratory Animals, and AAALAC accreditation
guidelines. The protocol was approved by the Duke University
and Duke University Medical Center Institutional Animal Care
and Use Committee (protocol number: A266–08–10). All efforts
were made to minimize suffering. The clinical isolates were
collected and stored in the Duke Infectious Disease Repository
under an IRB-approved protocol entitled ‘‘Database and specimen
repository for infectious diseases-related studies’’ (#CR3_
Pro00005314). The specimens were de-identified discarded
samples collected as part of routine clinical practice and were
exempt from patient written informed consent.
Strains and growth conditions
C. neoformans strains used in this study are listed in Table S1.
YL99a strain was obtained by an extra round of H99 and KN99a
backcrossing. The tested clinical isolates were taken directly from
the CSF of patients with cryptococcal meningitis from USA (HC
isolates, Duke patients) and from South Africa (RCT isolates,
obtained from Tihana Bicanic and Tom Harrison). The indicated
mating types were determined by crosses and confirmed with
PCR, and the serotyping of clinical isolates was determined by
PCR using STE20 mating-type- and serotype-specific primer pairs
[71]. Strains were maintained in 280uC glycerol stocks and grown
on YPD medium (1% yeast extract, 2% Bacto Peptone, and 2%
dextrose). To perform mating assays, cells of opposite mating type
were mixed in water, spotted on 5% V8 juice agar medium
(pH 5.0) or Murashige and Skoog (MS) medium minus sucrose
and incubated at room temperature in the dark [72–75]. For spot
assays, cultures grown in liquid YPD were diluted to 2610
6 cells/
ml and serially diluted tenfold. Then, 5 ml of each culture was
spotted onto YPD or YPD plus 2 mM H2O2 (Sigma) or YPD plus
20 ng/ml rapamycin (LC Laboratories) plates and incubated at
the indicated temperatures. For benomyl sensitivity assays, 5 mlo f
fivefold serial dilutions were spotted onto YPD plates with DMSO
(control) or with 10 or 20 mg/ml benomyl (Sigma). Growth
differences were imaged following incubation of the plates for
72 h.
Generation of gene disruption and complemented
strains
Strains with gene disruptions were generated using an overlap
PCR approach and biolistic transformation in serotype A congenic
strains H99 and KN99a as previously described [76]. For gene
deletions, the 5’ and 3’ flanking regions of apoptotic genes and
BUB1 were amplified from H99 genomic DNA and the dominant
selectable markers NAT, NEO, or HYG were amplified with the
universal M13F and M13R primers from plasmids pJAF13,
pJAF12 and pJAF15 respectively. A second overlap PCR
amplified a full-length deletion cassette containing the three
previous fragments. The products of overlap PCR were purified,
precipitated onto gold microcarrier beads (0.6 mm, Bio-Rad), and
the H99 strain was biolistically transformed [5,26]. Stable
transformants were selected for resistance to nourseothricin
(100 mg/ml), G418 (100 mg/ml), or hygromycin B (300 mg/ml),
screened by PCR, and confirmed by Southern blot. The a mca1
mutant background was used for disruption of MCA2 by biolistic
transformation. The resulting a mca1 mca2 mutant was crossed to
strain KN99a to generate single and double mutants with opposite
mating types (see Table S1). The aif1 mca1 mca2 triple mutants are
progeny obtained from the cross of a aif1with a mca1 mca2 (see
Table S1). For complementation, an overlap PCR product with
the NEO marker and the wild-type AIF1 gene containing its native
promoter and terminator from strain H99 was generated. The
PCR product was biolistically transformed into aif1 mutant and
RCT17 backgrounds. Transformants were selected for resistance
to G418 (100 mg/ml) and confirmed by PCR. The sequences of
primers used are listed in Table S2.
TUNEL assay
TdT-mediated dUTP nick end labeling (TUNEL) assays were
performed as described previously [5,26] with the following
modifications. Log-phase cultures were diluted to an OD600 of 0.1
and treated with 2 mM H2O2 (Sigma) for 3 h at 37uC. Cells were
fixed for 1 h at room temperature with 3.7% formaldehyde
(Sigma) and washed with PBS. After treatment with 5% b-
mercaptoethanol in SPM (1.2 M sorbitol; 50 mM K-phosphate,
pH 7.3; and 1 mM MgCl2) for 1 h at 37uC with gentle agitation,
cells were washed with SPM and then digested with 10 mlo f
zymolyase
TM (Zymo Research, 4 U/mL), 100 mg of lysing
enzymes from Trichoderma harzianum (Sigma), and 0.1% bovine
serum albumin (Sigma) in 1 ml of spheroplasting buffer (1 M
sorbitol; 10 mM EDTA; and 100 mM sodium citrate, pH 5.8) for
40 min at 37uC with gentle agitation. Spheroplasts were gently
harvested at 1600 rpm for 5 min at 4uC and washed three times
with SPM to remove the enzymes. Samples were permeabilized
with 0.5 ml of fresh prepared 0.1% Triton X-100, 0.1% sodium
citrate solution in cold SPM for 2 min in ice, washed twice with
SPM, and incubated with 50 ml TUNEL reaction mixture (In Situ
Cell Death Detection Kit, Roche) for 60 min at 37uC in dark and
humid conditions. Cells were washed with PBS and immediately
analyzed by epifluorescence microscopy (see next section) or flow
cytometry. TUNEL positive cells were quantified by collecting
10,000 events on the FL1 (FITC) channel of a FACSCalibur flow
cytometer (Becton Dickinson) using CellQuest software (Becton
Dickinson). Cell debris were excluded using the side and forward
scatter dot-plot and a negative control (fixed and permeabilized
wild-type cells incubated in 50 ml of TUNEL solution without
terminal transferase) and a positive control [fixed and permeabi-
lized wild-type cells treated with 0.1 mg/ml DNase I (Sigma) for
10 min at room temperature to induce DNA strand breaks prior to
TUNEL labeling] were used to determine the percentage of
TUNEL positive cells.
Annexin V assay
Exposed phosphatidylserine was detected by reaction with
FITC-coupled Annexin V (Apoptosis Detection kit, Oncogene
Figure 5. Detection of fluconazole resistance and aneuploidy in clinical isolates with AIF1 deficiency. A. Clinical isolate RCT 17 shows a
high frequency of FLC
R clone generation, a phenotype similar to that observed in the aif1 mutant. B. aCGH analysis of a FLC
R colony isolated from
RCT 17 on Etest assay showing Chr1 disomy (CPS104). C. qRT-PCR revealed that RCT 17, HC-4, and HC-6 have reduced AIF1 expression. Strains were
grown overnight in liquid YPD medium, and total RNA was collected and reverse-transcribed into cDNA (WT-RT represents control without reverse
transcriptase). Relative expression levels represent mean DCt values normalized to ACT1 expression levels and relative to expression values in the H99
wild-type strain (value arbitrarily set to 1). Bars represent standard deviation for triplicates. D. aCGH analysis of clinical isolate HC-4, showing partial
duplication for chromosome 9. E. aCGH analysis of clinical isolate HC-6, showing partial duplication for chromosome 6. Vertical bars in red indicate
amplifications, and in green deletions, that are statistically significant. Vertical bars in gray indicate no DNA copy number alteration or amplifications
or deletions that did not meet the statistical settings.
doi:10.1371/journal.ppat.1002364.g005
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were treated with 2 mM H2O2 (Sigma) for 3 h at 37uC. Yeast cells
were washed with PBS, treated with 5% b-mercaptoethanol, and
spheroplasted as described above for the TUNEL assay.
Spheroplasts were washed two times with SPM and once with
Binding Buffer diluted to 1x with 2 M sorbitol, and double stained
with FITC-Annexin V and propidium iodine (PI) for 20 min at
room temperature in the dark dark as described by [77]. Annexin
V-positive, PI-negative cells were quantified by collecting 10,000
events on the FL1 (FITC) and FL2 (PE) channels of a
FACSCalibur flow cytometer (Becton Dickinson) using CellQuest
software (Becton Dickinson).
Microscopy
To evaluate TUNEL assays, cells were mounted in ProLong
Gold antifade reagent with DAPI (Molecular Probes). Brightfield,
differential interference microscopy (DIC), and fluorescence
images were captured with a Zeiss Axio Imager widefield
Figure 6. Apoptotic-defective mutants show defective basidiospore formation. A. Sporulation defects were observed in bilateral matings
between a and a strains: H99 x KN99a; CPS3 x CPS15; YPH104 x CPS13; and CPS89 x CPS116. Basidia with zero, two or four spore chains formed after
14 days on MS media were counted using 40X microscopy (inset shows representative images). B-D. Scanning electron microscopy images of the
wild-type H99 x KN99a (B), aif1 x aif1 mutant CPS3 x CPS15 (C), and mca1 mca2 x mca1 mca2 mutant YPH104 x CPS13 (D) crosses. Basidia and
basidiospore chains are shown in greater detail in the middle and right panels. Bars, 10 mm.
doi:10.1371/journal.ppat.1002364.g006
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cooled-CCD camera (Hamamatsu) using DAPI and FITC
channels. Images were interfaced with MetaMorph software
(Universal Imaging) and processed with PhotoShop (Adobe).
Mating structures were captured with an Eclipse E400
microscope (Nikon) equipped with a DXM1200F digital camera
(Nikon). Images were interfaced with ACT-1 software (Nikon) and
processed with PhotoShop (Adobe). For scanning electron
microscopic analysis, mating plates were processed at the North
Carolina State University Center for Electron Microscopy,
Raleigh, NC, USA. Areas of interest were excised intact from
the agar and fixed with 0.1 M sodium cacodylate (pH 6.8) buffer
containing 3% glutaraldehyde for several days at 4uC. Samples
were then washed for 1 h in cold sodium cacodylate buffer three
times, dehydrated through a graded series of cold 30% and 50%
ethanol for 1 h each, and held overnight in 70% ethanol.
***
Figure 7. Apoptosis-like cell death is important for competitive fitness. A. Competition assays showing that ALCD is important to
population fitness in vitro. Strains H99 and CPS76 (H99 HYG), H99 and CPS3, H99 and YPH104, and H99 and CPS89 were paired at the same cell
density and each mixture was inoculated into YPD liquid medium at a final density of 8610
4 cells/ml and incubated at 30uC for the indicated times.
An aliquot of each culture was plated on YPD solid medium, and incubated for 2 days before it was replica plated onto YPD, YPD-HYG, YPD-NAT, and
YPD-NEO media. The ratios of survival for each strain at 0, 24, 48, and 72 h are shown for one representative of three experiments and *indicates
significance at p,0.05. B. Virulence of the apoptotic defective strains in the murine model shows no significant difference to wild-type. Mice were
infected intranasally with strains H99, CPS3, YPH104, and CPS89.
doi:10.1371/journal.ppat.1002364.g007
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and 100% ethanol at 4uC, warming to room temperature in the
100% ethanol, followed by two additional 1-h washes with 100%
ethanol at room temperature. The dehydrated samples were
critical-point dried with liquid CO2 in a SAMDRI-795 (Tousimis)
for 15 min and mounted on stubs with silver paint to ensure good
adhesion and conductivity. Finally, the samples were coated with
50 A ˚ of gold/palladium using a Hummer 6.2 sputter coater
(Anatech) and held in a vacuum desiccator until viewed at 15 kV
on a JSM 5900LV scanning electron microscope (JEOL),
photographed with a Digital Scan Generator (JEOL) image
acquisition system, and processed with PhotoShop (Adobe).
Etest
In vitro antifungal susceptibility to FLC and AMB was
determined by Etest (AB Biodisk) according to the manufacturer’s
instructions. Cells grown to mid-log phase were washed in 0.85%
NaCl and diluted to an OD600 of 0.5 (,1 McFarland turbidity).
Inocula were applied with cotton swabs in RPMI-1640 agar
(Sigma) supplemented with 2% glucose and buffered to pH 7.0
with MOPS and allowed to dry completely before applying the
Etest strip. Plates were incubated at 35uC for 72 h and the MIC
was determined as the first growth inhibition ellipse.
Isolation of fluconazole resistant strains
Distinct colonies within the inhibition halo around the FLC
strip during Etest assays were replica plated onto YPD agar and
YPD agar plus 32 mg/ml FLC and incubated at 30uC. Isolates
able to grow on the FLC plate after 2 days were inoculated into
5 ml YPD liquid and grown overnight at 30uC with agitation.
Liquid cultures were tested by Etest assays and used to make
gDNA (later used for ploidy analysis) and 280uC glycerol stocks.
For virulence experiments and FLC resistance stability assays,
280uC glycerol stocks were inoculated into 5 ml YPD liquid and
grown overnight at 30uC with agitation.
Array comparative genomic hybridization
Genomic DNA was extracted using alkyltrimethyl ammonium
bromide buffer (CTAB) as described by [78]. The quality of the
purified DNA was examined on an agarose gel and quantified in a
Qubit fluorometer (Invitrogen) using the Quant-iT dsDNA BR kit
according to Invitrogen’s instructions. Then 2.5 mg of DNA was
sonicated to generate ,500-bp fragments, which were labeled
with Perkin Elmer Cy3-dUTP (reference DNA from H99 wild-
type strain) or Cy5-dUTP (strain of interest) using the Random
Primer Reaction of BioPrime Array CGH Genomic Labeling
System (Invitrogen). Labeled reference and sample DNA were
combined in a 1:1 ratio, purified using Microcon 30K Centrifugal
Filter Units (Millipore), and concentrated in a Speed Vac Plus
SC110 (Savant Instruments). Samples were resuspended in 50 ml
of Long Oligo Hybridization Solution (Corning), denatured at
95uC for 5 min, and applied to the C. neoformans whole genome 70-
mer oligonucleotide spotted array version II (Washington
University Genome Sequencing Center) covered with a LifterSlip
Microarray Coverslip (Erie Scientific Company). Arrays were
hybridized at 42uC for 16 h and subsequently washed twice with
1X SSC, 0.3% SDS heated to 42uC, followed by two washes in
0.2X SSC, and two final washes with 0.05X SSC at room
temperature for two minutes each. Slides were dried by
centrifugation, scanned with a GenePix 4000B scanner (Axon
Instruments), and analyzed using GenePix Pro 6.0 software
(Molecular Devices). GeneSpring GX 7.3 (Agilent Technologies)
was used to perform Lowess normalization of the data, and an
S-plus script was used to remove exon-junction probes and to log2
Figure 8. Mechanisms controlling ALCD, mating, and aneuploidy. Both Aif1 and the metacaspases are required for sporulation in C.
neoformans. The Aif1-mediated ALCD eliminates aneuploid cells from the population and contributes to the emergence of FLC
R cells.
doi:10.1371/journal.ppat.1002364.g008
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experimental arrays and from four control hybridizations (Cy3-
reference strain DNA x Cy5-reference strain DNA) were analyzed
with CGH-Miner software [79], which uses the Clusters Along
Chromosomes method to identify DNA copy number alterations.
Raw data for the regions of gain/loss identified by the algorithm
were then manually inspected to confirm the calls or eliminate
occasional errors induced by noise. The plots of log2 data as a
function of chromosomal nucleotide position were created using a
sliding-window of 10 consecutive probes and a targeted false
discovery rate (FDR, i.e., the expected proportion of false posi-
tive results) of 0.01. Vertical bars were plotted in red for
amplifications and green for deletions that are statistically sig-
nificant. Vertical bars in gray indicate no DNA copy number
alteration or amplifications or deletions that did not meet the
statistical settings.
Fluconazole resistance and reversion rates
FLC resistance rates were calculated by fluctuation analysis
using the method of the median [80]. To measure FLC resistance
rates, individual colonies of each strain were grown non-selectively
in YPD agar from 280uC glycerol stocks. Twelve independent
cultures from isolated colonies were grown in YPD liquid medium
overnight at 30uC. Yeast cells were collected by centrifugation,
washed with water, and serial dilutions were plated on YPD agar
and YPD agar with 32 mg/ml FLC to determine the number of
viable cells and the number of FLC
R cells, respectively. The
median number of FLC
R cells in the different cultures was
corrected for dilution factors, fractions plated, and number of
viable cells. The numbers of FLC
R cells were ranked, and the 3
rd
and 10
th ranks were used to calculate the lower and upper limits of
the 95% confidence interval [81]. Strains resistant to FLC were
used to calculate the reversion rates after approximately 20
generations. Non-selectively grown cultures from -80uC glycerol
stocks were incubated at 30uC for 24 h in YPD liquid. Culture
dilutions were plated on YPD agar, and 100 individual colonies
were replica plated onto YPD agar and YPD agar plus 32 mg/ml
FLC, followed by incubation at 30uC. Colonies unable to grow on
the FLC plate after 2 days were considered revertants.
Virulence studies
Virulence assays were conducted using a murine inhalation
model of cryptococcosis. Cohorts of 4- to 6-week-old female A/
JCr mice were anesthetized by intraperitoneal injection of
Nembutal (37.5 mg/kg) and infected intranasally with 5610
4 cells
in 50 ml of PBS pipetted slowly into the nares. Inoculum
concentration was confirmed by plating serial dilutions in YPD
agar and counting colony forming units (CFU) after 2 days. Mice
were monitored twice daily, and those that showed signs of severe
morbidity (weight loss, extension of the cerebral portion of the
cranium, abnormal gait, paralysis, seizures, convulsions, or coma)
were sacrificed by CO2 inhalation. The survival rates of animals
were plotted against time, and p-values were calculated with the
Mann-Whitney U test. In the first experiment using FLC
treatment (Figure S5), 10 mice per strain were treated with
20 mg/kg/day FLC intraperitoneally, while control groups of 10
mice received only saline. Treatment started 24 h after inoculation
of yeasts and was continued for 14 days. In the second experiment
using FLC treatment (Figure 3C), 10 mice of about 20 g each were
treated with 100 mg/kg/day FLC in the sole source of drinking
water as described by [35]. Water intake was recorded daily for
each cage (all 5 mice were assumed to drink the same volume) and
averaged 0.23 ml/g. Treatment started 24 h after infection and
was continued through day 60 with water being replaced every 2
to 3 days. FLC concentrations for each cage were recalculated
based on weights of the animals and the water intake measured
during the preceding days. Three euthanized mice in each treated
group were dissected on the days indicated post-infection; their
brains and lungs were removed, weighed, and homogenized in
1 ml sterile PBS. Serial dilutions of the organ samples were plated
on Sabouraud-dextrose agar plus 100 mg/ml chloramphenicol and
incubated at 30uC. Up to 50 individual colonies were replica
plated onto YPD agar and YPD agar plus 32 mg/ml FLC and
incubated at 30uC. Colonies unable to grow on the FLC plate after
2 days were considered revertants. Isolates able to grow on FLC
were further tested by aCGH, qPCR, and Etest assays as described
above.
RNA extraction and cDNA synthesis
Yeast cells for RNA extraction were grown in YPD liquid
culture overnight and were harvested the following day and
washed. RNA preparations were isolated with the RNAeasy Mini
Kit (Qiagen), including the DNase treatment step, and reverse
transcriptase reactions were performed using AffinityScript RT-
RNase (Stratagene).
Quantitative PCR and RT-PCR analysis
Quantitative PCR reactions were performed in an Applied
Biosystems 7500 Real-Time PCR System using Brilliant SYBR
Green qRT-PCR master mix (Stratagene). PCR thermal cycling
conditions were an initial step at 95uC for 5 min followed by 40
cycles at 95uC for 15 s, 60uC for 20 s and 72uC for 20 s. In each
assay, "no-template" controls were included and melting curve
analysis was performed to confirm a single PCR product. All
experiments were done in triplicate for both the gene of interest
and the control gene (GPB1 or ACT1, see figure legends). Data
were normalized to the control genes and relative expression was
determined by the 2
2DDCT method. The sequences of primers
used are listed in Table S2. Detection of Chr1 disomy by qPCR
was adapted from the method described by [81].
Mating cell fusion assays
To perform the mating cell fusion assays, wild-type and mutant
strains containing HYG, NAT, or NEO resistance genes were
grown in YPD liquid overnight. Yeast cells were washed and
adjusted to 5610
6 cells/ml, mixed 1:1, and grown on V8 medium
(pH 5.0) in the dark for 48 h. The mating colonies were collected
by scraping, resuspended in sterile water, and serial dilutions were
plated onto YPD medium containing hygromycin, nourseothricin,
and/or G418 to select for cell-cell fusion products that have two
drug-resistance markers (one from either parent). Plates were
incubated at 30uC for 3 days until colonies formed and were then
counted. The average number of colonies in triplicate assays was
calculated and the fusion efficiency in apoptotic-mutants was
determined as a function of the wild-type.
Competitive fitness and growth curve assays
For competition assays, overnight cultures in YPD were washed
three times with sterile water and adjusted to a density of
1610
7 cells/ml. The following strains were paired in a 1:1 ratio:
H99 and CPS76 (H99 HYG); H99 and CPS3; H99 and YPH104;
and H99 and CPS89. Each mixture was inoculated onto fresh
YPD medium and incubated at 30uC for the indicated times. Fifty
isolated colonies from each time point were replica plated onto
selective media and survival rates were calculated. Growth curves
were determined by diluting the strains to OD600 of 0.01 in YPD
and incubation at 30uC without agitation. The turbidity of
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microdilution plate reader (Sunrise, Tecan). Readings were
corrected for background (YPD media, no cells added), averaged,
and plotted versus time in Excel (Microsoft Office).
Statistical analysis
All quantitative data are reported as means 6 standard
deviation and are derived from at least three independent
experiments. The significance of the data was assessed using
two-tailed t-tests to compare mutants with the wild-type strain. For
comparisons of mice survival data, the logrank test was performed
using Prism 4 (GraphPad Software). A p-value of less than 0.05
was considered significant.
Accession numbers
AIF1 (CNAG_04521); BUB1 (CNAG_03184); COX1 (CNAG_
09009); ENDOG (CNAG_02204); IAP1 (CNAG_04708); MCA1
(CNAG_04636), MCA2 (CNAG_06787), and AIF1 from RCT 17
strain (JN606083).
Supporting Information
Figure S1 C. neoformans cells treated with hydrogen
peroxide display apoptotic phenotypes, but apoptotic
markers can not be detected after treatment with
amphotericin B and fluconazole. A. Annexin V assay
indicating externalization of phosphatidylserine (PS) after treat-
ment with 2 mM H2O2 . Wild-type H99 strain and the aif1, mca1
mca2, and aif1 mca1 mca2 mutant strains were treated with 2 mM
H2O2 for 3 hr, double stained with FITC-labeled Annexin V and
propidium iodide (PI) and analyzed by flow cytometry. Percent-
ages of Annexin V-positive/PI-negative cells (early apoptotic cells),
Annexin V-negative/PI- positive cells (necrotic cells), and Annexin
V/PI-double-positive cells (late apoptotic or necrotic cells) are
indicated. Data represent mean 6 standard deviation. ** and ***
indicates significance at p,0.01 and p,0.001 compared to WT.
B. Representative flow cytometry pictograms of cells that were
treated with 2 mM H2O2, 0.125 mg/ml AMB or 64 mg/ml FLC
and labeled with TUNEL assay (the percentage of TUNEL-
positive cells is indicated inside each panel).
(EPS)
Figure S2 Apoptotic mutants are more resistant to
H2O2. Two independent aif1, mca1 mca2, and aif1 mca1 mca2
mutants were grown on YPD media with 0 or 2 mM H2O2 and
incubated at 37uC for 2 days.
(EPS)
Figure S3 qPCR analysis of FLC
R strains described in
Table 3. A. Position of ERG11, ACT1, and AFR1 genes on Chr1.
B. Copy number of the indicated genes on Chr1 determined by
qPCR. Relative gene copy number represent mean DCt values
normalized to GPB1 (CNAG_06699; chromosome 7) and relative
to copy number values in the H99 wild-type strain (value arbi-
trarily set to 1). Bars represent standard deviation for triplicates.
(EPS)
Figure S4 aCGH analysis of FLC
R strains described in
Table 3. The log2 of the ratio of the hybridization signal of
genomic DNA from the indicated FLC
R strains relative to the
hybridization signal from H99 wild-type strain were plotted as a
function of its chromosomal location. Each chromosome was
color-coded and their numbers are listed at the bottom.
(EPS)
Figure S5 Virulence assay and efficacy of fluconazole
therapy in murine model of cryptococcosis. FLC
R clones
are more virulent than wild-type and aif1 mutant backgrounds in
the presence of FLC treatment of murine cryptococcal infections.
Mice were infected intranasally with strains H99, CPS3, CPS18,
and CPS24 and treated with 20 mg/kg/day of FLC.
(EPS)
Figure S6 Fluconazole sensitivity of different strains
using Etest assays. A. Reconstitution of Aif1 complements the
increased fluconazole heteroresistance of RCT 17 strain. B. Etest
strip assays showing that an aif1 diploid strain (CPS80) exhibits a
higher frequency of the intrinsic adaptive fluconazole hetero-
resistant phenotype when compared to a wild-type diploid strain
(CPS83).
(EPS)
Figure S7 Apoptotic-defective mutants show reduced
mating and defective secretion of mating pheromone. A.
Mating assays between the indicated a and a strains on V8
medium (pH 5.0, upper panels) and MS agar (lower panels)
incubated for 14 days at room temperature in the dark, showing
that mutants produce less hyphae than the wild-type strain during
bilateral crosses. Plates were observed at 40X magnification to
visualize mating hyphae and basidia. B. Apoptotic defective
strains were confronted with opposite mating type crg1 mutant
strains on V8 medium (pH 5.0) and incubated for 7 days at room
temperature in the dark. The apoptotic mutant strains stimulated
less conjugation tube formation by the crg1 strains.
(EPS)
Figure S8 Apoptotic-defective mutants exhibit cell fu-
sion defects during mating. Fusion products from the
indicated crosses were selected on YPD medium containing
hygromycin, nourseothricin, and/or G418. Plates were observed
at 40X magnification to visualize the formation of hyphae by the
fusion products. Fusion efficiency was determined by counting the
number of visible large colonies. Strains from the left: YSB119 x
YSB121; CPS70 x CPS15; YPH90 x CPS11; CPS9 x CPS5; and
CPS76 x CPS13.
(EPS)
Figure S9 Loss of apoptosis-like cell death does not
influence growth rate. Growth curves of the indicated strains
in liquid YPD medium at 30uC without agitation. Bars represent
standard deviation for quadruplicate assays.
(EPS)
Table S1 Strains used in this study.
(DOCX)
Table S2 Primers used in this study
(DOCX)
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